Literature DB >> 24604116

Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer BT474 cells.

Rui Wang1, Zhi Li1, Hui Guo1, Wei Shi1, Yue Xin1, Weilong Chang2, Tao Huang1.   

Abstract

Previous studies have demonstrated that caveolin 1 acts as a tumor suppressor in breast cancer, however, few studies have demonstrated that caveolin 1 also serves as a tumor promoter in breast cancer. In the present study, caveolin 1 small interfering RNA was used to knock down caveolin 1 expression in order to investigate the association between caveolin 1 and the proliferation and metastatic abilities of human breast cancer BT474 cells. The results revealed that cell proliferation, migration and invasion were attenuated by caveolin 1 knockdown in BT474 cells. Furthermore, caveolin 1 knockdown in BT474 cells arrested cells in the G0/G1 phase and decreased the number of cells in the S phase. In addition, caveolin 1 knockdown decreased the activation of the extracellular signal-regulated kinase 1/2 pathway and inhibited the expression of cell cycle-associated proteins (cyclin D1, c-Fos and β-catenin), whilst the expression of E-cadherin was increased. Furthermore, the protein expression of matrix metalloproteinase-2, -9 and -1 was also inhibited by caveolin 1 knockdown. In combination, these results demonstrated that caveolin 1 knockdown had a tumor suppressing effect on BT474 cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24604116     DOI: 10.3892/mmr.2014.2018

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

1.  Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells.

Authors:  Hannah Schmucker; Walker M Blanding; Julia M Mook; Jessica F Wade; Jang Pyo Park; Kerri Kwist; Hiral Shah; Brian W Booth
Journal:  Cell Oncol (Dordr)       Date:  2017-11-27       Impact factor: 6.730

2.  ∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.

Authors:  Elisa Caiola; Eleonora Marrazzo; Simona Alesci; Massimo Broggini; Mirko Marabese
Journal:  Tumour Biol       Date:  2015-09-04

3.  Downregulation of caveolin-1 in chronic rhinosinusitis with and without nasal polyps.

Authors:  Hai Lin; Dong Lin; Xi-Sheng Xiong; Xiong-Xiong Dai; Ting Lin
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-19       Impact factor: 2.503

4.  Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma.

Authors:  Koroku Kato; Hiroki Miyazawa; Hisano Kobayashi; Natsuyo Noguchi; Daniel Lambert; Shuichi Kawashiri
Journal:  Pathol Oncol Res       Date:  2020-01-06       Impact factor: 3.201

5.  Activation of immediate-early response gene c-Fos protein in the rat paralimbic cortices after myocardial infarction.

Authors:  Ji Yun Ahn; Hyun-Jin Tae; Jeong-Hwi Cho; In Hye Kim; Ji Hyeon Ahn; Joon Ha Park; Dong Won Kim; Jun Hwi Cho; Moo-Ho Won; Seongkweon Hong; Jae-Chul Lee; Jeong Yeol Seo
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

Review 6.  Caveolin-1: An Oxidative Stress-Related Target for Cancer Prevention.

Authors:  Shengqi Wang; Neng Wang; Yifeng Zheng; Jin Zhang; Fengxue Zhang; Zhiyu Wang
Journal:  Oxid Med Cell Longev       Date:  2017-05-04       Impact factor: 6.543

Review 7.  Cell Intrinsic and Extrinsic Mechanisms of Caveolin-1-Enhanced Metastasis.

Authors:  America Campos; Renato Burgos-Ravanal; María Fernanda González; Ricardo Huilcaman; Lorena Lobos González; Andrew Frederick Geoffery Quest
Journal:  Biomolecules       Date:  2019-07-29

Review 8.  Sex Bias in Differentiated Thyroid Cancer.

Authors:  Valentine Suteau; Mathilde Munier; Claire Briet; Patrice Rodien
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

9.  Targeting the raft-associated Akt signaling in hepatocellular carcinoma.

Authors:  Yuan Liu; Ji-Yun Lv; Jian-Fei Shi; Mei Yang; Shu-Hong Liu; Zhi-Wei Li; Hong-Bo Wang; Shao-Geng Zhang; Zhen-Wen Liu; Jin-Biao Ding; Dong-Ping Xu; Jing-Min Zhao
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.